The Pharmaceutical ingredient manufacturing and sales operations will be transferred to API Corporation and food chemical operations will be transferred to Taisho Technos, effective 1 July 2012.
API is a consolidated subsidiary of Mitsubishi Chemical and Taisho Technos is a wholly owned consolidated subsidiary of Mitsui Sugar.
Mitsubishi is working to build a management foundation for the discovery and global provision of new drugs.
By reorganizing operations through the business transfer, the Mitsubishi expects to focus management resources on its pharmaceutical operations.